Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized methotrexate monitoring in adults with Crohn's disease
NL-OMON50118Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in Crohn's disease, sponsored by Vrije University Medical Center. Primary endpoints: Step-Up-Therapy-Free-Survival and MTX-polyglutamate concentration in red blood cells. Started May 2019; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON50118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50118.